Kristine B. Degn

One Week’s Treatment With the Long-Acting Glucagon-Like Peptide 1 Derivative Liraglutide (NN2211) Markedly Improves 24-h Glycemia and α- and β-Cell Function and Reduces Endogenous Glucose Release in Patients with Type 2 Diabetes

Kristine B. Degn, Claus Bogh Juhl, Jeppe Sturis et al. · Diabetes · 2004 · 425 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Effect of Intravenous Infusion of Exenatide (Synthetic Exendin-4) on Glucose-Dependent Insulin Secretion and Counterregulation During Hypoglycemia

Kristine B. Degn, Birgitte Brock, Claus Bogh Juhl et al. · Diabetes · 2004 · 256 citations · Full text

Medicine, Endocrinology, Pharmacology +16

Effects of the Long-Acting Human Glucagon-Like Peptide-1 Analog Liraglutide on β-Cell Function in Normal Living Conditions

Andrea Mari, Kristine B. Degn, Birgitte Brock et al. · Diabetes Care · 2007 · 84 citations · Full text

Medicine, Endocrinology, Pharmacology +9

In Vivo Selection of a Unique Tandem Repeat Mediated Azole Resistance Mechanism (TR₁₂₀) in<i>Aspergillus fumigatus cyp51A</i>, Denmark

Rasmus Krøger Hare, Jan Berg Gertsen, Karen Marie Thyssen Astvad et al. · Emerging infectious diseases · 2019 · 56 citations · Full text

Life Sciences, Genetics, Microbiology +17

The Insulin Secretagogues Glibenclamide and Repaglinide Do Not Influence Growth Hormone Secretion in Humans but Stimulate Glucagon Secretion during Profound Insulin Deficiency

Torben Østergård, Kristine B. Degn, Mari-Anne Gall et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 17 citations

Life Sciences, Endocrinology, Pharmacology +16